| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/02/2005 | WO2005033265A9 Optimized multi-epitope constructs and uses thereof |
| 06/02/2005 | WO2005032470A3 Compositions and methods for treating burns |
| 06/02/2005 | WO2005028625A3 Consensus/ancestral immunogens |
| 06/02/2005 | WO2005018575A3 Estrogen receptor modulators and uses thereof |
| 06/02/2005 | WO2005013889A9 Truncated fragments of alpha-synuclein in lewy body disease |
| 06/02/2005 | WO2005009463A3 Antigen-presenting cell vaccines and methods of use thereof |
| 06/02/2005 | WO2005004909A3 Method of enhanced immunogenicity to meningococcal vaccination |
| 06/02/2005 | WO2004112832A3 Immunogenic compositions comprising multiple gonococcal antigens |
| 06/02/2005 | WO2004110384A3 Hiv-1 envelope glycoproteins having unusual disulfide structure |
| 06/02/2005 | WO2004096136A3 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 06/02/2005 | WO2004094473A3 Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 06/02/2005 | WO2004092384A3 Means and methods for diagnosing and treating affective disorders |
| 06/02/2005 | WO2004087058A3 Targeted mhc class i alpha3 vaccine delivery systems |
| 06/02/2005 | WO2004074320A3 Therapeutic targets in cancer |
| 06/02/2005 | WO2004071414A3 Therapeutic anti-hcv (al9) compounds |
| 06/02/2005 | WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 06/02/2005 | WO2004041212A3 Apkc isoforms in nervous system disorders and cancer |
| 06/02/2005 | WO2004037182A3 Active specific immunotherapy of cancer metastasis |
| 06/02/2005 | WO2004031358A3 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 06/02/2005 | WO2003087375A8 Cartilage differentiation regulating gene |
| 06/02/2005 | WO2003072032A3 Sterile immunogenic non-tumorigenic tumor cell compositions and methods |
| 06/02/2005 | US20050119471 RNA viral sequences for use in development of vaccine to prevent gastrointestinal disorders in infants and young children |
| 06/02/2005 | US20050119464 Protein |
| 06/02/2005 | US20050119458 Transport protein for use in identifying modulator for prevention and treatment of cell proliferative, skin and psychological disorders; anticonvulsants; insecticides; pesticides; anthelmintics |
| 06/02/2005 | US20050119210 Using genes encoding transmembrane protein as markers; targets for cancer therapy; drug screening |
| 06/02/2005 | US20050119208 Composition and method for treating lupus nephritis |
| 06/02/2005 | US20050119206 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 06/02/2005 | US20050119204 Osteopontin-related compositions and methods |
| 06/02/2005 | US20050118698 Propagating viral particle in BHK (baby hamster kidney) and MDCK (mandine darby canine kidney) cell lines; for use as bioreactor for producing drugs and/or diagnostic agents |
| 06/02/2005 | US20050118659 Bacterial polypeptide for use in diagnosis, prevention and treatment of microbial infection |
| 06/02/2005 | US20050118656 Methods for diagnosis and treatment of epithelial-derived cancers |
| 06/02/2005 | US20050118655 Using helminth mixture as therapeutic tool in treatment of autoimmune and allergic disorders; antihelmintics |
| 06/02/2005 | US20050118638 Using thyrotrophin (TSH) receptor as diagnostic tool in detection of autoimmune diseases; competive binding assay |
| 06/02/2005 | US20050118597 Peptide II |
| 06/02/2005 | US20050118573 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 06/02/2005 | US20050118566 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins |
| 06/02/2005 | US20050118275 vaccines; forming a water-in-oil-in-water emulsion that contains water, organic solvent and biodegradable polymer, followed by removal of the organic solvent from the emulsion to form microparticles, after which toxoid and/or polysaccharide containing antigens are adsorbed on the microparticles |
| 06/02/2005 | US20050118251 Novel DNA-based vaccine against the encephalitis alphaviruses |
| 06/02/2005 | US20050118222 A macrocyclic lactone (eprinomectin) and antigens against ticks; oily vehicle allows to solubilize the world's first injectable Eprinomectin, in doses of 200-250 mu g/kg of live-weight, with specific tick antigens |
| 06/02/2005 | US20050118201 Formalin inactivated preparations of mycobacteria, e.g., M. bovis, mixed with oil-containing nonphospholipid paucilamellar lipid vesicles e.g. Novasomes (reg); can be used on immunocomprised patients |
| 06/02/2005 | US20050118200 Two or more inactivated or attenuated Mycoplasma bovis biotypes, inactivated Mycoplasma alkalescens, an adjuvant and excipient; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia |
| 06/02/2005 | US20050118199 Process for covalently conjugating polysaccharides to microspheres or biomolecules |
| 06/02/2005 | US20050118198 Polysaccharide vaccine for staphylococcal infections |
| 06/02/2005 | US20050118197 Given repeating trisaccharide unit of mannose units; polysaccharide-protein conjugates useful in diagnosis of or vaccination against H pyroli |
| 06/02/2005 | US20050118196 Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor |
| 06/02/2005 | US20050118195 Virus causing respiratory tract illness in susceptible mammals |
| 06/02/2005 | US20050118194 Oral vaccine, method for its preparation and use thereof |
| 06/02/2005 | US20050118193 Live, attenuated, invasive bacterium that infects a mammalian host cell, and releases exogenous RNA into the cytoplasm of the host cell; can express e.g. immunogens, ribozymes; vaccines, cancer or viral disease treatment via gene expression inhibition |
| 06/02/2005 | US20050118191 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| 06/02/2005 | US20050118190 Staphylococcus antigen and vaccine |
| 06/02/2005 | US20050118189 Mutant Hin47 protein with decreased protease activity, and a high molecular weight protein of a strain of non-typeable Haemophilus influenzae; may be combined with diphtheria or tetanus toxoids, pertussis antigens or non-virulent poliovirus; immunization; otitis media |
| 06/02/2005 | US20050118188 HIV antigen and DC-cholesterol |
| 06/02/2005 | US20050118186 Treating ovarian or colorectal cancer by immunizing against the tumor rejection antigen PRAME and other tumor-associated antigen(s) such as NY-ESO-1 also known as CTAG-1 (Cancer-Testis Antigen-1) and SSX-2, also known as Hom-Mel-40 a cancer-testis antigen |
| 06/02/2005 | US20050118184 Compositions and methods for enhancing the immunogenicity of antigens |
| 06/02/2005 | US20050118183 Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 06/02/2005 | US20050118178 Use of t-cell immune response cdna7 (tirc7) in angiogenic and anti-angiogenic therapy |
| 06/02/2005 | US20050118173 Compositions and methods to accelerate hematologic recovery |
| 06/02/2005 | US20050118172 Humanized antibody CAMPATH-1H administered with steroid (hydrocortisone) |
| 06/02/2005 | US20050118171 Treatment of rheumatoid arthritis with CD99 antagonists |
| 06/02/2005 | US20050118170 Use of discoidin domain receptor 1 (ddr1) and agents that affect the ddr1/collagen pathway |
| 06/02/2005 | US20050118169 For inflammatory diseases; rheumatoid arthritis; hybridoma cell lines |
| 06/02/2005 | US20050118168 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor |
| 06/02/2005 | US20050118167 Parenteral pharmaceutical composition containing humanized monoclonal antibody fragment and stabilizing method thereof |
| 06/02/2005 | US20050118165 useful for imaging such tumors; scintigraphic detection, diagnosis, prognosis, monitoring and therapy of Met-bearing tumors |
| 06/02/2005 | US20050118163 Antibody-containing solution pharmaceuticals |
| 06/02/2005 | US20050118162 Treatment of micro-organism infection |
| 06/02/2005 | US20050118161 Hevein-binding monoclonal antibodies |
| 06/02/2005 | US20050118157 Treatment of central nervous system damage |
| 06/02/2005 | US20050118140 Madin Darby Canine Kidney cells are virally infected and cultured in suspension on an industrial scale to produce the active ingredient, and then mixed with a carrier or dilluent |
| 06/02/2005 | US20050118139 Canine papillomavirus E genes are codon-optimized to enhance expression in host cells; the vector is an adenovirus vector or a plasmid vector, and the genes are from a human papillomavirus serotype; prevention and prophylaxis |
| 06/02/2005 | US20050118117 Methods for identifying risk of melanoma and treatments thereof |
| 06/02/2005 | US20050118101 Delivery across skin or blood brain barrier; such as N-(fluorescein-5-yl)-thioureido-N'-Adoa-(polylysine)7-NH2 TFA salt |
| 06/02/2005 | DE4139840B4 Antigen-Zubereitung zum Nachweis von H. pylori Antigen preparation for the detection of H. pylori |
| 06/02/2005 | CA2747871A1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 06/02/2005 | CA2554635A1 Compounds, compositions containing such compounds and methods of treatment of autoimmune diseases using such compounds |
| 06/02/2005 | CA2547079A1 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 06/02/2005 | CA2546873A1 Surface-located campylobacter jejuni polypeptides |
| 06/02/2005 | CA2546840A1 Immunization against chlamydia infection |
| 06/02/2005 | CA2546836A1 Immunization against chlamydia infection |
| 06/02/2005 | CA2546794A1 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 06/02/2005 | CA2546566A1 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 06/02/2005 | CA2546406A1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 06/02/2005 | CA2546401A1 The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis |
| 06/02/2005 | CA2546397A1 Biological materials and uses thereof |
| 06/02/2005 | CA2546383A1 Rescue agents for treating botulinum toxin intoxications |
| 06/02/2005 | CA2546355A1 Novel atypical pneumonia-causing virus |
| 06/02/2005 | CA2546285A1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 06/02/2005 | CA2546237A1 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
| 06/02/2005 | CA2546195A1 The use of anti biotics as vaccine adjuvants |
| 06/02/2005 | CA2545944A1 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure |
| 06/02/2005 | CA2545939A1 Immunoglobulin preparations having increased stability |
| 06/02/2005 | CA2545935A1 Methods for modulating the th2 immune response to an antigen by adding or removing activated carbonyl groups from the antigen |
| 06/02/2005 | CA2545893A1 Anti-hydroxylase antibodies and uses thereof |
| 06/02/2005 | CA2545886A1 Methods of characterizing infectious bursal disease virus |
| 06/02/2005 | CA2545806A1 Methods of modulating immunity |
| 06/02/2005 | CA2543072A1 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
| 06/02/2005 | CA2532881A1 Anthrax vaccine |
| 06/02/2005 | CA2528549A1 Use of epha4 and modulator of epha4 for diagnosis, treatment and prevention of cancer |
| 06/02/2005 | CA2515890A1 Novel insertion sites in pox vectors |
| 06/01/2005 | EP1536015A1 Promoters for expression in modified vaccinia virus ankara |